NorthWest Biotherapeutics Inc (NWBO)

[Maverick0408]

No one is questioning the product, it effectiveness, its safety profile, combo potential and above all the KOLs supporting the ph 3 results and science. But there are many ph 3 successful trials and FDA approved products in healthcare that failed to capitalize over the years and remain a boutique shop or disappear because of lethargic execution and not making the right strategic moves at the right time.

If you care so much for the patients, why wouldn’t you want the management to pass the baton on to big pharma that can scale this very quickly rather than the snails pace at which this team is moving.